Factors associated with the use of reperfusion therapy in patients with acute myocardial infarction and ST segment elevation in Spain: The register of acute myocardial infarction in hospitals project (PRIAMHO II);Factores asociados al uso de la reperfusión en pacientes con infarto agudo de miocardio y elevación del segmento ST en España: Proyecto de Registro del Infarto Agudo de Miocardio en Hospitales (PRIAMHO II)

Medicina Intensiva

Volumn 27, Issue 10, 2003, Pages 653-661

  Ancillo, P ^a   Bosch, X ^b   Loma Osorio, A ^c   Pabon P ^d   Rodriguez J J ^e   Aros F ^c   Cunat J ^f   Heras, M ^b   Lopez Bescos L ^g   Marrugat, J ^h   Torrado, E ⁱ  

^a HOSPITAL GENERAL DE SEGOVIA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c HOSPITAL TXAGORRITXU   (Spain)

^d HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^e HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^f HOSPITAL UNIVERSITARIO LA FE   (Spain)

^g HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^h INST MUNIC D INVESTIGACIO MEDICA   (Spain)

ⁱ Hospital General de Segovia ^*

Author keywords

Acute coronary syndrome; Acute myocardial infarction; Coronary unit; Fibrinolysis; Mortality; Percutaneous coronary intervention; Register; Reperfusion

Indexed keywords

FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; FEMALE; FIBRINOLYSIS; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HOSPITALIZATION; HUMAN; HYPERTENSION; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; RISK FACTOR; SEX DIFFERENCE; ST SEGMENT ELEVATION; STROKE;

EID: 10744221506     PISSN: 02105691     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0210-5691(03)79988-4     Document Type: Article

References (29)

1. Marrugat J, Elosua R, Martí H. Epidemiología de la cardiopatía isquémica en España: estimación del número de casos y de las tendencias entre 1997 y 2005. Rev Esp Cardiol 2002;55:337-46.
2. The Joint European Society of Cardiology/ American College of Cardiology Committee. Myocardial Infarction Redefined-A Consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 2000;36:959-69.
3. Boersma E, Mercado N, Poldermans D, Gardien M, Vos J, Simoons ML. Acute myocardial infarction. Lancet 2003;361:847-58.
4. Weaver WD, Simes RJ, Betriu A, Grines CL, Zijlstra F, García E, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA 1997;278:2093-8.
5. Fox KA, Goodman SG, Klein W, Brieger D, Steg PG, Dabbous O, et al. Management of the acute coronary syndromes. Variations in practice and outcome. Findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2002;23:1177-89.
6. Rogers WJ, Canto JG, Lambrew CT, Tiefenbrunn AJ, Kinkaid B, Shoultz DA, et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 y 3. J Am Coll Cardiol 2000;36:2056-63.
7. Hasdai D, Behar S, Wallentin L, Danchin N, Gitt AK, Boersma E, et al. A prospective survey of the characteristics, treatment and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin. The Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J 2002;23:1190-201.
8. Eagle KA, Goodman SG, Avezum A, Budaj A, Sullivan CM, López-Sendón J, for the GRACE investigators. Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE). Lancet 2002;359:373-7.
9. Cabadés A, Marrugat J, Arós F, López-Bescós L, Pereferrer D, de los Reyes M, et al, en nombre de los investigadores del estudio "Proyecto de Registro de Infarto Agudo de Miocardio Hospitalario". Bases para un registro hospitalario de infarto agudo de miocardio en España. El estudio PRIAMHO. Rev Esp Cardiol 1996;49:393-404.
10. Bosch X, Sambola A, Arós F, López-Bescós L, Mancisidor X, IIIa J, et al, en representación de los investigadores del estudio PRIAMHO. Utilización de la trombólisis en los pacientes con infarto agudo de miocardio en España: observaciones del estudio PRIAMHO. Rev Esp Cardiol 2000;53:490-501.
11. Cabadés A, López-Bescós L, Arós F, Loma-Osorio A, Bosch X, Pabón P, et al, en nombre de los investigadores del estudio PRIAMHO. Variabilidad en el manejo y pronóstico a corto y medio plazo del infarto de miocardio en España: el estudio PRIAMHO. Rev Esp Cardiol 1999;52:767-75.
12. Estudio PRIAMHO II. Definiciones operativas. http://www. scisquemica.net/PROY/priamho2/triptico.htm
13. Report of the Joint International Society and Federation of Cardiology/Word Health Organization Task Force on standarization on clinical nomenclature. Nomenclature and criteria for diagnosis of ischemic heart disease. Circulation 1979;79:607-9.
14. WHO MONICA Project Principal Investigators. The World Health Organization MONICA Project (Monitoring Trends and Determinants in Cardiovascular Disease): a major international collaboration. J Clin Epidemiol 1988;41:105-14.
15. Antman EM, McCabe CH, Gurfinkel EP, Turpie AG, Bernink PJ, Salein D, et al. Enoxaparin prevents death and cardiac schemic events in unstable angina/non-Q wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. Circulation 1999;100:1593-601.
16. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-402.
17. Sarko J, Pollack CH. Beyond the twelve-lead electrocardiogram: diagnostic tests in the evaluation for suspected acute myocardial infarction in the emergency department. Part II. J Emerg Med 1998;16:67-78.
18. The GUSTO investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-82.
19. Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf RM, et al. ACC/AHA Guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on management of acute myocardial infarction). J Am Coll Cardiol 1996;28:1328-428.
20. Arós F, Cuñat J, Loma-Osorio A, Torrado E, Bosch X, Rodríguez JJ, et al. Manejo del IAM en España en el año 2000. El estudio PRIAMHO II. Rev Esp Cardiol [en prensa].
21. Eagle K. Lessons from GRACE: the Global Registry of Acute Coronary Events. Eur Heart J 2002;4(Suppl E):E24-31.
22. Marrugat J, Sala J. Registros de morbi-mortalidad en cardiología: métodos. Rev Esp Cardiol 1998;50:48-57.
23. Aguayo E, Reina A, Colmenero M, Barranco M, Pola MD, Jiménez MM, y Grupo ARIAM. Análisis de los retrasos en el tratamiento del síndrome coronario agudo. Datos del registro ARIAM. Med Intensiva 1999;24:273-9.
24. Arós F, Loma-Osorio A, Alonso A, Alonso JJ, Cabadés A, Coma-Canella I. Guías de actuación clínica en el infarto agudo de miocardio. Rev Esp Cardiol 1999;52:919-56.
25. Weaver WD, Cerqueira M, Hallstrom AP, Litwin PE, Martin JS, Kudenchuk PJ, et al. Prehospital-initiated vs. Hospital-iniciated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. JAMA 1993;270:1211-6.
26. Morrison LJ, Verbeek PR, McDonald AC, Sawadsky BV, Cook DJ. Mortality and prehospital thrombolysis for acute myocardial infarction. A meta-analysis. JAMA 2000;283:2686-92.
27. Braunwald E. Reperfusion therapy fo acute myocardial infarction: historical context and future promise. Eur Heart J Supplements 2002;4(Suppl E):E10-4.
28. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolitic therapy for acute myocardial infarctin: a quantitative review of 23 randomised trial. Lancet 2003;361:13-20.
29. Ottesen MM, Kober L, Jorgensen S, Torp-Pedersen C, on behalf of the TRACE study group. Consequences of overatilization and underatilization of thrombolytic therapy in clinical practice. J Am Coll Cardiol 2001;37:1581-7.